Xtant Net Income Per E B T from 2010 to 2024

XTNT Stock  USD 0.37  0.01  2.63%   
Xtant Medical Net Loss yearly trend continues to be comparatively stable with very little volatility. Net Loss is likely to outpace its year average in 2024. From the period from 2010 to 2024, Xtant Medical Net Loss quarterly data regression had r-value of  0.10 and coefficient of variation of  139.40. View All Fundamentals
 
Net Loss  
First Reported
2010-12-31
Previous Quarter
(0.64)
Current Value
(0.60)
Quarterly Volatility
0.6246718
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Xtant Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Xtant Medical's main balance sheet or income statement drivers, such as Interest Expense of 5.3 M, Total Revenue of 53.7 M or Gross Profit of 34 M, as well as many indicators such as Price To Sales Ratio of 1.4, Dividend Yield of 0.0 or PTB Ratio of 2.49. Xtant financial statements analysis is a perfect complement when working with Xtant Medical Valuation or Volatility modules.
  
Check out the analysis of Xtant Medical Correlation against competitors.

Latest Xtant Medical's Net Income Per E B T Growth Pattern

Below is the plot of the Net Income Per E B T of Xtant Medical Holdings over the last few years. It is Xtant Medical's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Xtant Medical's overall financial position and show how it may be relating to other accounts over time.
Net Income Per E B T10 Years Trend
Very volatile
   Net Income Per E B T   
       Timeline  

Xtant Net Income Per E B T Regression Statistics

Arithmetic Mean0.45
Geometric Mean0.40
Coefficient Of Variation139.40
Mean Deviation0.55
Median0.11
Standard Deviation0.62
Sample Variance0.39
Range1.8416
R-Value0.10
Mean Square Error0.42
R-Squared0.01
Significance0.71
Slope0.01
Total Sum of Squares5.46

Xtant Net Income Per E B T History

2024 -0.6
2023 -0.64
2021 1.21
2020 1.04
2017 1.01
2016 1.0

About Xtant Medical Financial Statements

Xtant Medical shareholders use historical fundamental indicators, such as Net Income Per E B T, to determine how well the company is positioned to perform in the future. Although Xtant Medical investors may analyze each financial statement separately, they are all interrelated. The changes in Xtant Medical's assets and liabilities, for example, are also reflected in the revenues and expenses on on Xtant Medical's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Net Loss(0.64)(0.60)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Xtant Stock Analysis

When running Xtant Medical's price analysis, check to measure Xtant Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xtant Medical is operating at the current time. Most of Xtant Medical's value examination focuses on studying past and present price action to predict the probability of Xtant Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xtant Medical's price. Additionally, you may evaluate how the addition of Xtant Medical to your portfolios can decrease your overall portfolio volatility.